These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
473 related items for PubMed ID: 15621017
21. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Hardy J, Selkoe DJ. Science; 2002 Jul 19; 297(5580):353-6. PubMed ID: 12130773 [Abstract] [Full Text] [Related]
22. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation. Guix FX, Ill-Raga G, Bravo R, Nakaya T, de Fabritiis G, Coma M, Miscione GP, Villà-Freixa J, Suzuki T, Fernàndez-Busquets X, Valverde MA, de Strooper B, Muñoz FJ. Brain; 2009 May 19; 132(Pt 5):1335-45. PubMed ID: 19251756 [Abstract] [Full Text] [Related]
23. NMDA receptor-dependent signaling pathways that underlie amyloid beta-protein disruption of LTP in the hippocampus. Yamin G. J Neurosci Res; 2009 Jun 19; 87(8):1729-36. PubMed ID: 19170166 [Abstract] [Full Text] [Related]
24. Localization of beta-secretase memapsin 2 in the brain of Alzheimer's patients and normal aged controls. Sun A, Koelsch G, Tang J, Bing G. Exp Neurol; 2002 May 19; 175(1):10-22. PubMed ID: 12009756 [Abstract] [Full Text] [Related]
25. Hyperphosphorylated tau deposition parallels prion protein burden in a case of Gerstmann-Sträussler-Scheinker syndrome P102L mutation complicated with dementia. Ishizawa K, Komori T, Shimazu T, Yamamoto T, Kitamoto T, Shimazu K, Hirose T. Acta Neuropathol; 2002 Oct 19; 104(4):342-50. PubMed ID: 12200619 [Abstract] [Full Text] [Related]
26. Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice. Ribé EM, Pérez M, Puig B, Gich I, Lim F, Cuadrado M, Sesma T, Catena S, Sánchez B, Nieto M, Gómez-Ramos P, Morán MA, Cabodevilla F, Samaranch L, Ortiz L, Pérez A, Ferrer I, Avila J, Gómez-Isla T. Neurobiol Dis; 2005 Dec 19; 20(3):814-22. PubMed ID: 16125396 [Abstract] [Full Text] [Related]
27. Neuronal COX-2 expression and phosphorylation of pRb precede p38 MAPK activation and neurofibrillary changes in AD temporal cortex. Hoozemans JJ, Veerhuis R, Rozemuller AJ, Arendt T, Eikelenboom P. Neurobiol Dis; 2004 Apr 19; 15(3):492-9. PubMed ID: 15056456 [Abstract] [Full Text] [Related]
28. Decreased estrogen receptor-alpha expression in hippocampal neurons in relation to hyperphosphorylated tau in Alzheimer patients. Hu XY, Qin S, Lu YP, Ravid R, Swaab DF, Zhou JN. Acta Neuropathol; 2003 Sep 19; 106(3):213-20. PubMed ID: 12819990 [Abstract] [Full Text] [Related]
29. alpha-Internexin immunoreactivity reflects variable neuronal vulnerability in Alzheimer's disease and supports the role of the beta-amyloid plaques in inducing neuronal injury. Dickson TC, Chuckowree JA, Chuah MI, West AK, Vickers JC. Neurobiol Dis; 2005 Mar 19; 18(2):286-95. PubMed ID: 15686957 [Abstract] [Full Text] [Related]
30. Calcium-binding protein secretagogin-expressing neurones in the human hippocampus are largely resistant to neurodegeneration in Alzheimer's disease. Attems J, Preusser M, Grosinger-Quass M, Wagner L, Lintner F, Jellinger K. Neuropathol Appl Neurobiol; 2008 Feb 19; 34(1):23-32. PubMed ID: 17961140 [Abstract] [Full Text] [Related]
31. Sequestration of RNA in Alzheimer's disease neurofibrillary tangles and senile plaques. Ginsberg SD, Crino PB, Lee VM, Eberwine JH, Trojanowski JQ. Ann Neurol; 1997 Feb 19; 41(2):200-9. PubMed ID: 9029069 [Abstract] [Full Text] [Related]
32. [Therapy of Alzheimer disease]. Kovács T. Neuropsychopharmacol Hung; 2009 Mar 19; 11(1):27-33. PubMed ID: 19731816 [Abstract] [Full Text] [Related]
33. [Significance of tau in the development of Alzheimer's disease]. Takashima A. Brain Nerve; 2010 Jul 19; 62(7):701-8. PubMed ID: 20675874 [Abstract] [Full Text] [Related]
34. Up-regulation of cell division cycle (cdc) 2 kinase in neurons with early stage Alzheimer's disease neurofibrillary degeneration. Pei JJ, Braak H, Gong CX, Grundke-Iqbal I, Iqbal K, Winblad B, Cowburn RF. Acta Neuropathol; 2002 Oct 19; 104(4):369-76. PubMed ID: 12200623 [Abstract] [Full Text] [Related]
35. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment. Attems J, Jellinger KA. Clin Neuropathol; 2006 Oct 19; 25(6):265-71. PubMed ID: 17140156 [Abstract] [Full Text] [Related]
36. A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration. Amadoro G, Corsetti V, Stringaro A, Colone M, D'Aguanno S, Meli G, Ciotti M, Sancesario G, Cattaneo A, Bussani R, Mercanti D, Calissano P. J Alzheimers Dis; 2010 Oct 19; 21(2):445-70. PubMed ID: 20571215 [Abstract] [Full Text] [Related]
37. Lysosome-associated membrane protein 1 (LAMP-1) in Alzheimer's disease. Barrachina M, Maes T, Buesa C, Ferrer I. Neuropathol Appl Neurobiol; 2006 Oct 19; 32(5):505-16. PubMed ID: 16972884 [Abstract] [Full Text] [Related]
38. Alzheimer's disease: report of two autopsy cases with a clinical diagnosis of corticobasal degeneration. Okazaki K, Fu YJ, Nishihira Y, Endo M, Fukushima T, Ikeuchi T, Okamoto K, Onodera O, Nishizawa M, Takahashi H. Neuropathology; 2010 Apr 19; 30(2):140-8. PubMed ID: 19780981 [Abstract] [Full Text] [Related]
39. Altered subcellular location of phosphorylated Smads in Alzheimer's disease. Ueberham U, Ueberham E, Gruschka H, Arendt T. Eur J Neurosci; 2006 Oct 19; 24(8):2327-34. PubMed ID: 17074053 [Abstract] [Full Text] [Related]
40. Assessments of the accumulation severities of amyloid beta-protein and hyperphosphorylated tau in the medial temporal cortex of control and Alzheimer's brains. Zhou XW, Li X, Bjorkdahl C, Sjogren MJ, Alafuzoff I, Soininen H, Grundke-Iqbal I, Iqbal K, Winblad B, Pei JJ. Neurobiol Dis; 2006 Jun 19; 22(3):657-68. PubMed ID: 16513361 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]